Related Experiment Video
Updated: Feb 6, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Catheter-Based Therapies for Pulmonary Emboli.
1Department of Radiology and Biomedical Imaging, Section of Vascular and Interventional Radiology, Yale University School of Medicine, PO Box 208042, 333 Cedar Street, New Haven, CT 06520-8042, USA.
For high-risk pulmonary embolism patients, advanced treatments like catheter-based therapies are recommended over standard anticoagulation. These methods aim for faster clot removal with potentially lower bleeding risks, though further research is needed for optimization.
Area of Science:
- Cardiovascular Medicine
- Interventional Pulmonology
- Thrombotic Disease Research
Background:
- Acute pulmonary embolism (PE) poses significant mortality and morbidity risks, especially in massive and submassive cases.
- Standard anticoagulation may be insufficient for high-risk PE patients requiring more aggressive interventions.
Purpose of the Study:
- To evaluate the role and potential benefits of advanced, catheter-based therapies for acute pulmonary embolism.
- To compare the efficacy and safety of interventional procedures versus systemic thrombolysis.
Main Methods:
- Review of catheter-based thrombolysis techniques for rapid clot reduction.
- Assessment of catheter-based mechanical thrombus debulking strategies.
- Consideration of combined catheter-based approaches.
Main Results:
- Catheter-based interventions offer rapid clot reduction and clinical improvement in high-risk PE.
- These methods may provide greater efficacy compared to systemic thrombolysis.
- Interventional approaches potentially carry a lower risk of bleeding complications.
Conclusions:
- More aggressive therapeutic strategies beyond anticoagulation are indicated for patients with massive or submassive PE.
- Catheter-based interventions represent promising options for managing high-risk acute pulmonary embolism.
- Further research is essential to define optimal low-dose thrombolysis regimens and develop advanced mechanical devices.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Gene Therapy
Group Therapy
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

